Generic placeholder image

Current Cancer Therapy Reviews


ISSN (Print): 1573-3947
ISSN (Online): 1875-6301

Ductal Carcinoma In Situ: Clinical Trials Update and Resolving Controversies

Author(s): Robert E. Roses and Henry M. Kuerer

Volume 8 , Issue 3 , 2012

Page: [182 - 188] Pages: 7

DOI: 10.2174/157339412802653173

Price: $65


The diagnosis of ductal carcinoma in situ (DCIS) has increased dramatically following the widespread adoption of screening mammography. DCIS has a favorable prognosis overall, but is associated with an increased risk of invasive breast cancer (IBC) and occasionally, with poor outcomes. The goal of the multidisciplinary treatment of DCIS is to prevent the development of invasive disease. The identification of patients at elevated risk for progression or recurrence who require more aggressive multimodality therapy and, conversely, those who can safely forgo elements of the current therapeutic armamentarium are important current challenges.

Keywords: Ductal Carcinoma in Situ, DCIS, Controversies, Clinical Trials

Rights & Permissions Print Export Cite as
© 2022 Bentham Science Publishers | Privacy Policy